ERBB2 and breast carcinoma: Stratifying this TCGA data set [17] by defined breast cancer subtypes based on Hu et al. [23] we demonstrated a pronounced loss of BDNF mRNA in subtypes associated with poor prognosis, i.e. luminal B, HER2-enriched and basal-like breast cancer (Figure 5B).